ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 956,15
-0,41%
Dow Jones
41 201,34
-0,36%
DAX
22 553,28
-0,51%
Brent Oil
70,195
-0,70%
Bitcoin
81 964,10
-2,05%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Verve Therapeutics Inc (VERV)

  7. Verve Therapeutics Inc (VERV) Actualités

VERV

Verve Therapeutics (VERV)

Verve Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VERV
DateHeureSourceTitreSymboleSociété
03/03/202522h05GlobeNewswire Inc.Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VERVVerve Therapeutics Inc
27/02/202514h57Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:VERVVerve Therapeutics Inc
27/02/202514h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VERVVerve Therapeutics Inc
27/02/202513h45Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VERVVerve Therapeutics Inc
27/02/202513h24Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:VERVVerve Therapeutics Inc
27/02/202513h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERVVerve Therapeutics Inc
27/02/202513h00GlobeNewswire Inc.Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:VERVVerve Therapeutics Inc
31/01/202517h11PR Newswire (US)Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law FirmNASDAQ:VERVVerve Therapeutics Inc
29/01/202513h00GlobeNewswire Inc.Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech ConferenceNASDAQ:VERVVerve Therapeutics Inc
13/01/202513h00GlobeNewswire Inc.Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 MilestonesNASDAQ:VERVVerve Therapeutics Inc
10/01/202515h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERVVerve Therapeutics Inc
08/01/202513h00GlobeNewswire Inc.Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:VERVVerve Therapeutics Inc
08/11/202420h17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VERVVerve Therapeutics Inc
05/11/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VERVVerve Therapeutics Inc
05/11/202413h00GlobeNewswire Inc.Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial ResultsNASDAQ:VERVVerve Therapeutics Inc
28/10/202415h00PR Newswire (US)Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERVNASDAQ:VERVVerve Therapeutics Inc
28/10/202410h45PR Newswire (US)Verve Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERVNASDAQ:VERVVerve Therapeutics Inc
17/10/202411h45PR Newswire (US)Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERVNASDAQ:VERVVerve Therapeutics Inc
14/10/202411h45PR Newswire (US)Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:VERVVerve Therapeutics Inc
10/10/202411h45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:VERVVerve Therapeutics Inc
30/09/202411h45PR Newswire (US)Investors in Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERVNASDAQ:VERVVerve Therapeutics Inc
23/09/202411h45PR Newswire (US)The Gross Law Firm Reminds Verve Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERVNASDAQ:VERVVerve Therapeutics Inc
19/09/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics Lawsuit - VERVNASDAQ:VERVVerve Therapeutics Inc
09/09/202416h33PR Newswire (US)Shareholders of Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERVNASDAQ:VERVVerve Therapeutics Inc
05/09/202411h45PR Newswire (US)Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:VERVVerve Therapeutics Inc
08/08/202413h00GlobeNewswire Inc.Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial ResultsNASDAQ:VERVVerve Therapeutics Inc
28/06/202413h00GlobeNewswire Inc.Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of DirectorsNASDAQ:VERVVerve Therapeutics Inc
31/05/202413h00GlobeNewswire Inc.Verve Therapeutics Announces Leadership UpdateNASDAQ:VERVVerve Therapeutics Inc
30/05/202422h01GlobeNewswire Inc.Verve Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:VERVVerve Therapeutics Inc
08/05/202413h00GlobeNewswire Inc.Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial ResultsNASDAQ:VERVVerve Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VERV

Dernières Valeurs Consultées

BIT
P1JHP5
BNP Paribas Issuance
ASX
SDF
Steadfast
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces